Can Changes in Leadership and FDA Dialogue Reshape Applied Therapeutics' (APLT) Path in Rare Diseases? [Yahoo! Finance]
Applied Therapeutics, Inc. (APLT)
Last applied therapeutics, inc. earnings: 11/13 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
million, and announced the resignation of Executive Chairman John Johnson for personal reasons. Recent regulatory updates on key drug candidates, ongoing R&D progress, and out-licensing arrangements are shaping expectations around the company's future growth opportunities in rare diseases. We'll explore how the dialogue with the FDA about govorestat's clinical development influences Applied Therapeutics' investment narrative. The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. What Is Applied Therapeutics' Investment Narrative? If you're thinking about Applied Therapeutics today, the big picture is all about buying into the high-risk, high-reward world of rare disease drug development, and the ability to manage setbacks along the way. The company's Q3 2025 update delivered some positives: revenue jumping to US$1 million and a sharply lower net loss, offering some reassu
Show less
Read more
Impact Snapshot
Event Time:
APLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APLT alerts
High impacting Applied Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
APLT
News
- Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $1.00 price target on the stock.MarketBeat
- Applied Therapeutics (NASDAQ:APLT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Applied Therapeutics Announces Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Applied Therapeutics Announces Corporate UpdatesGlobeNewswire
- Applied Therapeutics GAAP EPS of -$0.13 beats by $0.03 [Seeking Alpha]Seeking Alpha
APLT
Earnings
- 11/13/25 - Beat
APLT
Sec Filings
- 11/20/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- 11/13/25 - Form 10-Q
- APLT's page on the SEC website